Publication Cover
Journal of Dual Diagnosis
research and practice in substance abuse comorbidity
Volume 16, 2020 - Issue 1: Cannabis
792
Views
5
CrossRef citations to date
0
Altmetric
Reviews

Cannabis and Epilepsy

& ORCID Icon
Pages 75-82 | Received 27 Feb 2019, Accepted 21 Jun 2019, Published online: 06 Aug 2019
 

Abstract

Objective: In recent years, the use of cannabidiol in the treatment of refractory epilepsy has been increasingly investigated and has been gaining public support as a novel way to treat these disorders. Marijuana has been used for medical purposes for thousands of years, and a lot of research has been conducted over the last several decades into the chemistry and pharmacology of marijuana and its many compounds, including cannabidiol. Methods: Using PubMed, we performed a review of the literature regarding the history of cannabinoid use in treating epilepsy. Results and conclusions: There are historical and recent scientific developments that support the use of cannabidiol in rare severe epilepsy syndromes.

Acknowledgments

The authors of this article would like to thank the Epilepsy division at the UT Southwestern Medical Center as well as the Department of Neurology and Neurotherapeutics.

Disclosure statement

The authors have no disclosures.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 53.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 273.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.